Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Nucleai
Nucleai Overview
Nucleai is committed to harnessing the potential of spatial biology by providing pharmaceutical companies and clinicians with advanced AI-powered image analysis technology. The company’s platform is designed to enhance drug development, support treatment decisions, and improve patient lives.
Nucleai’s image analysis and biomarker discovery technology leverages real-world pathology along with clinical and molecular datasets to help better understand cancer biology, optimize patient stratification, and improve patient care.